| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |